Epidemiology and management of chronic thromboembolic pulmonary hypertension

Netherlands Journal of Medicine

Volumn 68, Issue 9, 2010, Pages 347-351

  Klok, F A ^a,b   Huisman, M V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN;

ASCITES; CARDIOVASCULAR RISK; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COMPUTER ASSISTED TOMOGRAPHY; CYANOSIS; DISEASE ASSOCIATION; DYSPNEA; ECHOCARDIOGRAPHY; ENDARTERECTOMY; FATIGUE; HEART CATHETERIZATION; HEART PALPITATION; HEART RIGHT VENTRICLE FAILURE; HEMATOLOGIC MALIGNANCY; HEMOPTYSIS; HEPATOMEGALY; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; LEG EDEMA; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG FUNCTION TEST; LUNG VENTILATION PERFUSION RATIO; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER FAILURE; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VALVE INSUFFICIENCY; REVIEW; SPLENECTOMY; SYNCOPE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VENTRICULOATRIAL SHUNT;

CHRONIC DISEASE; ENDARTERECTOMY; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; NETHERLANDS; PROGNOSIS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 77958004039     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Klok FA, Zondag W, van Kralingen KW, van Dijk AP, Tamsma JT, Heyning FH, et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med. 2010;181:501-6.
2. Klok FA, Mos ICM, Broek L, Tamsma JT, Rosendaal FR, de Roos A, et al. Risk of arterial cardiovascular events in patients after pulmonary embolism. Blood. 2009;114:1484-8.
3. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011-20.
4. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345:1465-72.
5. Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54 (Suppl 1):S85-96.
6. Riedel M, Stanek V, Widimsky J, Prerovsky I. Long-term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81:151-8.
7. Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, Haworth SG. Development and pathology of pulmonary hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S3-9.
8. Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:325-31.
9. Nijkeuter M, Söhne M, Tick LW, Kamphuisen PW, Kramer MH, Laterveer L, et al. Christopher Study Investigator. The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. Chest. 2007;131:517-23.
10. Azarian R, Wartski M, Collignon MA, Parent F, Hervé P, Sors H, et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med. 1997;38:980-3.
11. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J. 2000;15:440-8.
12. Keogh AM, Mayer E, Benza RL, Corris P, Dartevelle PG, Frost AE, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S67-77.
13. Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of thrombininduced endothelial cell permeability. Biochemistry (Mosc). 2002;67:75-84.
14. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. for the Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-64.
15. Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006;130:172-5.
16. Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res. 2009;124:256-8.
17. Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 2006;85:253-62.
18. Klok FA, van Kralingen KW, van Dijk APJ, et al. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 2009; doi:10.3324/haematol.2009.018960.
19. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573-619.
20. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology. 1992;182:393-8.
21. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160:523-8.
22. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76:1457-62.
23. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122-7.
24. Ghofrani HA, Schermuly RT, Rose F, Wiedemann R, Kohstall MG, Kreckel A, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2003;167:1139-41.
25. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:595-600.
26. Hoeper MM, Kramm T, Wilkens H, Schulze C, Schäfers HJ, Welte T, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest. 2005;128:2363-7.
27. Jaïs X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, et al; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52:2127-34.